VIE News and Press, Viela Bio Inc. From 05/13/20

Viela Bio, Inc. (VIE) Q1 2020 Earnings Conference Call May 13, 2020 17:00 ET Company Participants Mitchell Chan - Chief Financial Officer Bing Yao - Chairman & Chief Executive Officer Bill Ragatz - Vice President, Head of Commercial Jorn Drappa - Chief Medical Officer &...

VIELA BIO (NASDAQ: VIE ): Q1 GAAP EPS of -$0.80 misses by $0.10 . More news on: Viela Bio, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today reported financial results and provided program highlights for the first quarter ended Mar...

-Safety profile comparable to placebo control- -Potent depletion of plasmacytoid dendritic cells in peripheral blood and skin biopsies- -Dose-dependent improvements in Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) scores- GAITHERSBURG, Md., May 13, 2020...

GAITHERSBURG, Md., May 06, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, May 13, 2020 at&#x...

GAITHERSBURG, Md., April 30, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the election of Rachelle Jacques to its Board of Directors. As a veteran of the bi...

Mersana Therapeutics (NASDAQ: MRSN ) initiated with Buy rating and $14 (50% upside) price target at BTIG Research. Shares up  2%  premarket. More news on: Mersana Therapeutics, Inc., Viela Bio, Inc., Y-mAbs Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Rea...

Jazz Pharmaceuticals (NASDAQ: JAZZ ) initiated with Buy rating and $149 (51% upside) price target at Jefferies. More news on: Jazz Pharmaceuticals plc, Walgreens Boots Alliance, Inc., Acceleron Pharma Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Image source: The Motley Fool. Viela Bio Inc   (NASDAQ: VIE) Q4 2019 Earnings Call Mar 25, 2020 , 5:00 p.m. ET Operator Continue reading

Viela Bio, Inc. (VIE) Q4 2019 Earnings Conference Call March 25, 2020 5:00 P.M. ET Company Participants Mitchell Chan - Chief Financial Officer Bing Yao - Chairman and Chief Executive Officer Jorn Drappa - Chief Medical Officer, Head of Research and Development Bill Ragatz - Vi...